Lateral pancreaticoduodenectomy, more often referred to as a modified Puestow procedure, is a pillar of open pancreatic surgery. First performed in 1958, this procedure addresses complex chronic pancreatitis with a dilated pancreatic duct and normal pancreatic head while preserving much of the pancreatic parenchyma1. Primary indications for this operation include chronic pancreatitis with chronic pain, narcotic dependency, and poor quality of life. Drainage procedures typically involve relief of obstruction in the pancreatic duct while preserving the pancreatic head parenchyma. The Puestow procedure falls into the category of drainage procedures for chronic pancreatitis, a group that also includes the Partington and Rochelle modification and the Izbicki procedure2. The vast majority of patients with chronic pancreatitis present with the involvement of the pancreatic head and are thus not eligible for drainage procedures and instead undergo resection. The pancreaticoduodenectomy is an extensive procedure with resection of the pancreatic head, duodenum, and a portion of the stomach. The Beger and Frey procedures are also parenchymal resection procedures that involve the removal of the lesion from the pancreatic head while sparing the duodenum and more of the pancreatic parenchyma3.
For much of the history of treatment for chronic pancreatitis, drainage procedures and pancreaticoduodenectomy were the mainstay of treatment. The optimal surgical approach for chronic pancreatitis remains unanswered and should be individualized based on clinical, imaging, and endoscopic assessment. As detailed in the discussion, surgical drainage procedures have recently been shown to have significantly lower 90-day readmission rates and need for reintervention, with no differences in pain scores compared to resective procedures4. However, in the era of minimally invasive surgery, drainage procedures have fallen out of favor as compared with other current options: laparoscopic or robotic pancreaticoduodenectomy and duodenal-preserving pancreatic head resections5,6. While these procedures provide a safe and attainable treatment for the majority of chronic pancreatitis patients, they are highly morbid operations that resect already diseased parenchyma, further increasing the risk of endocrine and exocrine dysfunction. Pancreaticoduodenectomy is most often linked to delayed gastric emptying, bleeding, pancreatic insufficiency, and infection7. Distal pancreatectomy is most often complicated by pancreatic fistula and abscess formation/infection3,8,9. In the interest of preserving pancreatic parenchyma in the surgical treatment of chronic pancreatitis, robotic lateral pancreaticojejunostomy may have an underestimated utility.
Use of robotic surgery in the management of pancreatic disease has advanced rapidly in the past decade, similar to the implementation of laparoscopic surgery decades prior. Both robotic and laparoscopic approaches are associated with decreased recovery times and lower levels of post-operative pain, allowing patients to return to their day-to-day lives sooner10,11,12. The robotic platform has the additional benefits of 3-dimensional visualization with high magnification and articulating instruments, which is particularly advantageous with the manipulation of delicate pancreatic tissue and suturing complex anastomoses. The extent of a learning curve for robotic pancreatic surgery is controversial; however, it is generally agreed that mastery of port placement and coordination with laparoscopic assistance is critical13. As more surgeons graduate from training programs with this skill set, utilizing the versatility of the robotic platform to leverage a minimally invasive approach to all pancreatic procedures that are possible with open surgery is feasible and may improve outcomes associated with surgery for pancreatitis14.
This paper provides a clear and easily adaptable method for robotic-assisted lateral pancreatojejunostomy. As more surgical techniques are adapted to robotic surgery, we include the largely historical drainage approach in this growing list and ensure the technique is accessible to fellowship-trained hepatobiliary surgeons.
CASE PRESENTATION:
We report a 39-year-old male with no significant past medical history and no history of alcohol or tobacco use. He presents with recurrent episodes of pancreatitis for 5 years in the setting of gallstone pancreatitis, for which a laparoscopic cholecystectomy was performed at the time of his initial presentation. Unfortunately, the episodes recurred and worsened over time. After presentation to our facility, he underwent endoscopic retrograde cholangiopancreatography (ERCP), which revealed pancreatic divisum and pancreatic duct stricture at the neck, which could not be traversed for duct stent placement.
Diagnosis, Assessment, and Plan:
As previously stated, the patient had a significant pancreatic duct stricture in the neck of the pancreas, evidenced by the pancreatogram (Figure 1). Magnetic resonance cholangiopancreatography (MRCP) further elucidated irregular upstream dilation of the pancreatic duct in the body and tail of the pancreas (Figure 2). Importantly, these studies revealed no significant disease of the pancreatic head or major biliary involvement, indicating that this patient was a candidate for a robotic pancreatic drainage procedure to decompress the distal pancreatic duct, thereby limiting further episodes of pancreatitis.